Imugene Limited
Imugene Limited
  • 88
  • 164 177
Meet Garrett Gincley, Vice President of Cell Therapy, External Manufacturing, and Imugene Quality.
Meet Garrett Gincley, Vice President of Cell Therapy, External Manufacturing, and Imugene Quality. In this video, Garrett shares his passion for advancing azer-cel, an innovative off-the-shelf CAR T therapy developed from healthy donor T cells. With over five years of experience working on azer-cel, he expresses his excitement about its potential to be a lifesaving treatment for cancer patients worldwide. Join him as he discusses the exciting progress Imugene is making in the fight against cancer.
Переглядів: 340

Відео

Meet Tilanthi Jayawardena, Imugene’s Translational Sciences Lead for azer-cel.
Переглядів 20028 днів тому
Meet Tilanthi Jayawardena, Imugene’s Translational Sciences Lead for azer-cel. In this video, Tilanthi shares her journey in cell therapy, from her early work in 2019 to joining Imugene in 2023. She discusses the exciting progress of azer-cel in the clinic and its potential to make a significant impact for patients in need.
Investor webinar: Azer-cel trial update, September 2024
Переглядів 990Місяць тому
Watch the replay of Imugene's investor webinar held on 4 September 2024. During the webinar, Imugene's Managing Director and CEO Leslie Chong, along with Chief Medical Officer Dr. Paul Woodard, discuss the latest data from the azer-cel Phase 1b clinical trial in relapsed/refractory diffuse large B-cell lymphoma (DLBCL). This update follows the announcement made on 2 September 2024, highlighting...
Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL
Переглядів 547Місяць тому
Imugene Ltd (ASX: IMU) chief operating officer Brad Glover and CEO Leslie Chong sit down with Proactive’s Tylah Tully to discuss positive results from its Phase 1b clinical trial of azer-cel (azercabtagene zapreleucel), an allogeneic off-the-shelf CD19 CAR T therapy, in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL). This trial addresses a significant unmet need as all ...
CEO Leslie Chong And COO Dr Bradley Glover Speak With JustStocks Video
Переглядів 834Місяць тому
CEO Leslie Chong And COO Dr Bradley Glover Speak With JustStocks Video; Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)
CAR T Explained
Переглядів 7052 місяці тому
What do frozen samurai warriors and magic goggles have to do with treating cancer? Join Imugene on a journey into the future of cancer therapies, and learn how new genome editing technology-is used to make off-the-shelf, donor-derived CAR T cell therapies with the potential to change the way the world battles cancer.
Developing Cancer Cures through the ASX | Going Public w Leslie Chong & Paul Hopper
Переглядів 2,2 тис.2 місяці тому
Imugene Ltd (ASX: IMU) is excited to share the 12th episode of 'Going Public' on Australia's leading investing platform. This monthly series offers unique access to the entrepreneurs, founders, and executives who have taken their businesses public. In this episode, we delve into the remarkable journey of Imugene, a clinical-stage immuno-oncology company revolutionising cancer treatment with cut...
Leslie Chong & Dr Yuman Fong speak to JustStocks on latest With onCARlytics & MAST Clinical Trials
Переглядів 1,4 тис.3 місяці тому
Imugene Limited (ASX:IMU) CEO Leslie Chong And CF33 inventor Dr Yuman Fong provide an update to JustStocks Video on the latest with the company’s Phase 1 bile tract cancer study and Phase 1 onCARlytics trial.
Imugene begins VAXINIA trial for bile tract cancer
Переглядів 1,4 тис.3 місяці тому
Imugene Ltd (ASX:IMU, OTC:IUGNF) managing director and CEO Leslie Chong and strategic advisor Dr Yuman Fong sit down with Proactive’s Jonathan Jackson to discuss Professor Fong’s expertise and the latest company developments. Dr Fong is a world-renowned cancer researcher, physician and surgeon whose clinical work has focused on OV for more than 30 years. He is the inventor of OV CF33. Imugene h...
Imugene (ASX:IMU) doses first patient in IV arm of Phase 1 onCARlytics trial targeting solid cancers
Переглядів 6463 місяці тому
Our MD & CEO, Leslie Chong sits down with Proactive’s Jonathan Jackson to discuss our recent milestone: dosing the first patient in the intravenous (IV) infusion combination arm of our Phase 1 onCARlytics trial. This patient, diagnosed with cholangiocarcinoma, received treatment at City of Hope in California. Our OASIS trial is the first to combine a CD19-expressing oncolytic virus with a CD19-...
Imugene (ASX:IMU) | JMM & éthica Capital Innovation Interview \\ May 2024
Переглядів 9845 місяців тому
CEO & Managing Director Leslie Chong interview with JMM and éthica Capital 🔗 Stay Connected: www.imugene.com Follow us on Twitter: @TeamImugene Connect with us on LinkedIn: www.linkedin.com/company/imugene/ Explore more on our website: www.imugene.com #Imugene #CancerResearch #Biotech #Immunotherapy #Oncology #AusBiz
Imugene (ASX:IMU) | JMM & éthica Capital Innovation & Investment Insights | May 2024
Переглядів 2,3 тис.5 місяців тому
Imugene's CEO & Managing Director Leslie Chong recently delivered a dynamic 'stand-up and pitch' presentation to investors in Sydney. In her talk, she briefly recounted her journey to leading Imugene's team, which collectively boasts over 150 years of experience. She shared updates on the Phase 1B Study, the sale of our manufacturing facility in North Carolina, and our oncarlytic Phase One stud...
Investor webinar - Imugene Limited (ASX:IMU) & Kincell Bio Strategic Partnership Investor Webinar
Переглядів 1,1 тис.5 місяців тому
Join us for a comprehensive discussion on the newly announced strategic partnership between Imugene Limited (ASX: IMU) and Kincell Bio, LLC. This investor webinar, originally held on 18 April 2024, features insights from Imugene's Managing Director and CEO, Leslie Chong, COO Dr. Bradley Glover, and Kincell Bio's CEO, Dr. Bruce Thompson. Hosted by Imugene's U.S. Head of Investor Relations, Heath...
MD & CEO Leslie Chong Discusses Bile Tract Cancer Study Expansion & Strategic Partnership
Переглядів 6906 місяців тому
Join Leslie Chong, Managing Director & CEO of Imugene Ltd (ASX:IMU), as she provides an insightful update on the latest developments at Imugene. In this video, Dr. Chong discusses the expansion of our clinical study targeting Bile Tract Cancer, a crucial part of our VAXINIA MAST program. The expansion trial aims to enrol 10 patients, marking a significant step forward in our research efforts. A...
Leslie Chong Discusses Imugene's Strategic Partnership with Kincell Bio | AusBiz Interview
Переглядів 8746 місяців тому
Join Imugene’s Managing Director & CEO, Leslie Chong, in an insightful interview on AusBiz, where she discusses our groundbreaking strategic partnership with Kincell Bio. This partnership is set to enhance our efforts in pioneering new cancer treatments through advanced immuno-oncology therapies. In this interview, Leslie outlines the implications of our cutting-edge CAR T and oncolytic virothe...
Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
Переглядів 7456 місяців тому
Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
Imugene opens enrolment for Bile Tract Cancer expansion study
Переглядів 6286 місяців тому
Imugene opens enrolment for Bile Tract Cancer expansion study
Imugene Limited: ASX Small and Mid Cap Conference March 2024
Переглядів 8186 місяців тому
Imugene Limited: ASX Small and Mid Cap Conference March 2024
Imugene with Proactive at ASX Small and Mid Cap Conference
Переглядів 6816 місяців тому
Imugene with Proactive at ASX Small and Mid Cap Conference
Imugene (ASX:IMU) Presentation, NWR Virtual Healthcare Conference
Переглядів 7286 місяців тому
Imugene (ASX:IMU) Presentation, NWR Virtual Healthcare Conference
Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO
Переглядів 1,7 тис.7 місяців тому
Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO
Imugene progresses onCARlytics solid tumour trial to combination arm
Переглядів 4357 місяців тому
Imugene progresses onCARlytics solid tumour trial to combination arm
Imugene Ltd MD and CEO shares with JustStocks plans for Phase 1 onCARlytics Combination Study
Переглядів 8067 місяців тому
Imugene Ltd MD and CEO shares with JustStocks plans for Phase 1 onCARlytics Combination Study
Imugene's Presentation at the Capital HQ MasterClass
Переглядів 8307 місяців тому
Imugene's Presentation at the Capital HQ MasterClass
Imugene Ltd CEO & Managing Director Leslie Chong speaks with JustStocks
Переглядів 8328 місяців тому
Imugene Ltd CEO & Managing Director Leslie Chong speaks with JustStocks
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial
Переглядів 1 тис.8 місяців тому
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial
7 News Australia | Australian company Imugene; saving lives using a cancer eating virus
Переглядів 6 тис.8 місяців тому
7 News Australia | Australian company Imugene; saving lives using a cancer eating virus
Imugene steps up dosage at groundbreaking VAXINIA cancer trial
Переглядів 1,1 тис.8 місяців тому
Imugene steps up dosage at groundbreaking VAXINIA cancer trial
CEO Leslie Chong interview with Proactive Investors on Phase 1 MAST Results
Переглядів 7608 місяців тому
CEO Leslie Chong interview with Proactive Investors on Phase 1 MAST Results
Imugene Limited J.P. Morgan Healthcare Conference Presentation
Переглядів 1,4 тис.9 місяців тому
Imugene Limited J.P. Morgan Healthcare Conference Presentation

КОМЕНТАРІ

  • @maxthelionxmax9220
    @maxthelionxmax9220 28 днів тому

    God is with you

  • @d1skel452
    @d1skel452 28 днів тому

    Garret, Good luck and God Speed

  • @couldntgivafuk
    @couldntgivafuk 28 днів тому

    ……

  • @911aircooled5
    @911aircooled5 Місяць тому

    Fantastic progress IMU, well done. Looking forward to the H2 announcements.

  • @maxthelionxmax9220
    @maxthelionxmax9220 Місяць тому

    Well done to all the Imugune team. This is hugely important work. Keep going.

  • @CK-nu7ej
    @CK-nu7ej Місяць тому

    God’s will for Imugene to succeed in a safe cancer vaccine

  • @brianscheu5497
    @brianscheu5497 Місяць тому

    🎉😂 "off the shelf" cd19 targeting cancer therapy...with CF33 doing the infection and cd19 labelling..... patients will be diagnosed and treated the same day.....cured completely in 3 weeks by 2026....go team Imugene.....cancer on the ropes....wildfire on the cancer landscape....the biggest medical break through since penicillin.....you are making history !!!!

  • @Investwithmitch
    @Investwithmitch Місяць тому

    Congratulations to Imugene. The bottom line is sick people are getting better thanks to you.

  • @yuliayane6928
    @yuliayane6928 2 місяці тому

    What now?

  • @flomakasi
    @flomakasi 2 місяці тому

    amazing

  • @TheGutshotpro
    @TheGutshotpro 2 місяці тому

    The best description of CAR T I have seen.

  • @couldntgivafuk
    @couldntgivafuk 2 місяці тому

    Ok that was much more impressive

  • @andrewpaterson-y4y
    @andrewpaterson-y4y 2 місяці тому

    wow that is the best presentation to date of what IMU are developing. well done team!

  • @deano1432
    @deano1432 2 місяці тому

    Great video. Go Imugene!

  • @Sebastian80-ew1jn
    @Sebastian80-ew1jn 2 місяці тому

    Man this was kind of disappointing, I know it's under wraps most likely but I was hoping we'd hear updates. There are a not insignificant people that are looking to imugene oncolytic as their last hope. Any update on ORR or just FDA track would be a sigh of relief but I guess it won't be for another 10 years if we're lucky. Sad.

  • @couldntgivafuk
    @couldntgivafuk 2 місяці тому

    I call this one “let’s keep milking our shareholders”

  • @kentchambers7981
    @kentchambers7981 3 місяці тому

    I'd love to see what Imugene could do with a patient as a first treatment. Seems to me that all the trial patients are incredibly sick people with advanced cancers and compromised systems due to all the failed therapies they have already been through and we're still seeing CR's. Can only imagine how much more effective CF33 could be if it was administered straight after diagnosis

  • @donoo1021
    @donoo1021 3 місяці тому

    correct terminology should be "cancer is not detected" not "all the cancer is gone" 3:22 - looking forward to more data coming from this company.

  • @downstg
    @downstg 3 місяці тому

    Imugene is accomplishing amazing science. Patients will benefit from their work and many are waiting!

  • @barrymccosh9546
    @barrymccosh9546 3 місяці тому

    Why is it when we know that Chemotherapy and Radiation is ineffective in treating Bile Duct cancer do we have to wait for the patient to fail on this SOC before receiving treatment in the OASIS trial? It just doesn't make sense.

  • @EugenioTomasillo
    @EugenioTomasillo 3 місяці тому

    Truly inspiring, well done! When will we be able to see VAXINIA as a substitute of the chemotherapy? Thanks

  • @avbmitch9928
    @avbmitch9928 3 місяці тому

    Terrific to see Dr.Fong

  • @couldntgivafuk
    @couldntgivafuk 3 місяці тому

    You keep making all these claims it works and has essentially cured patients yet the shareholders are drowning.

  • @73maxoneit
    @73maxoneit 3 місяці тому

    Prostate cancer??

  • @DaddioTelevision
    @DaddioTelevision 3 місяці тому

    Goosebumps

  • @football24091
    @football24091 3 місяці тому

    Sharw price has tanked

  • @theapk666
    @theapk666 4 місяці тому

    Is it 100% successful treatment?

  • @dotagedrain7051
    @dotagedrain7051 5 місяців тому

    Too much news.. need revenue

  • @maxthelionxmax9220
    @maxthelionxmax9220 5 місяців тому

    Go Leslie and the Imugene team. 2024/2025 will be great years !

  • @luisitoputirecors1499
    @luisitoputirecors1499 5 місяців тому

    My brother is stage 4 prostate...he sudfer all his life for the violencia in Colombia .He survia a car bom were a lord drug Pablo Escobar placed in Bogotà, when he turn 40 a police shoot close to his face .cause the police officer made a huge mistake..and mistaken my brother for a thieve and now he is fighting for his life his name is Juan Mauricio Castellanos and l pray for a miracle...🔥🔥🔥🔥🔥

  • @JoyceNegrineyoga
    @JoyceNegrineyoga 5 місяців тому

    Thank You Imugene, your groundbreaking advances are brilliant! Congratulations!

  • @xergi123
    @xergi123 5 місяців тому

    will be interesting to see if the share price finally starts to move in the right direction, go Imugene!

  • @couldntgivafuk
    @couldntgivafuk 5 місяців тому

    This is all getting old.

    • @DeezNuts-jk8fq
      @DeezNuts-jk8fq 5 місяців тому

      I have plenty of money, you have shares, so sell them to me

  • @jaypakhan6397
    @jaypakhan6397 5 місяців тому

    Moving nicely. And we have the opportunity to enter this multi billion dollar market @ 1/100 ratio, Can't wait for next announcement. 👌

  • @couldntgivafuk
    @couldntgivafuk 6 місяців тому

    Endless promises.

  • @maxthelionxmax9220
    @maxthelionxmax9220 6 місяців тому

    Wishing Leslie and all the team well ! Keep going and rooting for you all

  • @arez0769
    @arez0769 6 місяців тому

    So if they hitting every mile stone, what does that mean for the shares will it 🚀

  • @couldntgivafuk
    @couldntgivafuk 6 місяців тому

    What the hell is this company doing lately.

  • @xergi123
    @xergi123 6 місяців тому

    Surely it should have gone up on the news, not down

  • @xergi123
    @xergi123 6 місяців тому

    How is the joke on me, numbnuts?

  • @xergi123
    @xergi123 6 місяців тому

    Lol, struggling to stay above 10 cents.

  • @arez0769
    @arez0769 6 місяців тому

    I wonder if the share will hit $100 if they been getting good news most of the time.

  • @73maxoneit
    @73maxoneit 6 місяців тому

    As stage 4 patient I hope you will move quickly!

  • @shanea9613
    @shanea9613 6 місяців тому

    Amazing technology. I hope it all works out

  • @xergi123
    @xergi123 6 місяців тому

    The share price never seems to move much? Definatly a company to invest in though. Well done IMU

  • @couldntgivafuk
    @couldntgivafuk 7 місяців тому

    So I'm confused... cancer has taken many more lives than COVID ever will... and yet after many many years we're still no closer to FDA approved human treatments. Yet the MRNA vaccine was released in under a year, completely untested.

    • @flomakasi
      @flomakasi 6 місяців тому

      Cancer is not a virus, and it does not bring people to hospitals in the same place at the same time. COVID has caused hospital entrances to become saturated

  • @Bill-fd8kt
    @Bill-fd8kt 7 місяців тому

    Any chance this would work for fibrolamellar? flHCC is ultra rare but desperately needs better treatments.

  • @inn8media
    @inn8media 7 місяців тому

    I hope this isn't just investor hype.